EpiData 软件在定量系统评价数据提取中的应用
周建国， 周权， 马虎 - 循证医学, 2014 - jebm.cn
… and Gefitinib sensitivity in nonsmall-cell lung cancer [J]. J Natl … Personalized medicine in
non-small-cell lung cancer: … Mass spectrometry to classify non-small-cell lung cancer patients for …
non-small-cell lung cancer: … Mass spectrometry to classify non-small-cell lung cancer patients for …
[PDF][PDF] 吉西他滨联合顺铂序贯吉非替尼治疗晚期非小细胞肺癌
过雪丹， 吴福林， 陈暑波， 徐伟， 黄庆 - 2012 - biomed.cnjournals.com
… High frequency of epidermal growth factor receptor mutations with complex patterns in
non-small cell lung cancers related to gefitinib responsiveness in Taiwan [J].Clin …
non-small cell lung cancers related to gefitinib responsiveness in Taiwan [J].Clin …
[HTML][HTML] 雷公藤甲素与吉非替尼序贯应用对人肺腺癌细胞H1975 存活及凋亡通路的影响
张鑫宇， 刘皈阳， 刘浩， 马涛 - Chinese Journal of Lung Cancer, 2015 - ncbi.nlm.nih.gov
… with advanced non-small cell lung cancer (… Gefitinib and Triptolide in H1975 (n=3).A:Pretreated
with triptolide 24 h, followed by gefitinib for 48 h; B:Treated concomitantly with gefitinib …
with triptolide 24 h, followed by gefitinib for 48 h; B:Treated concomitantly with gefitinib …
[PDF][PDF] 胰岛素样生长因子2 mRNA 结合蛋白2 (IGF2BP2) 在肺癌发生发展中的作用研究
刘鸿鸣 - 2017 - core.ac.uk
… A randomized, double-blind phase III study of icotinib versus gefitinib in patients with advanced
non-small cell lung cancer (NSCLC) previously treated with chemotherapy (ICOGEN) [J]. …
non-small cell lung cancer (NSCLC) previously treated with chemotherapy (ICOGEN) [J]. …
EGFR 靶向治疗的现状机遇和挑战
高琳， 虞永峰， 陆舜 - 中国肿瘤临床, 2021 - cjco.cn
… Efficacy and safety of gefitinib as thirdline treatment in NSCLC patients with activating …
analysis of first-line therapies with maintenance regimens for advanced non-small cell lung cancer …
analysis of first-line therapies with maintenance regimens for advanced non-small cell lung cancer …
[PDF][PDF] 周围型非小细胞肺癌CT 特征与EGFR 基因突变的相关性研究
李传俊， 罗燕， 吴晓涛， 梅东东， 徐坚民… - … JOURNAL OF CT AND …, 2018 - diagnoschina.com
… between CT characteristics of peripheral non-small cell lung cancer (NSCLC)and … cancer
and epidermal growth factor receptor exon 19 and exon 21 mutationstreated with gefitinib …
and epidermal growth factor receptor exon 19 and exon 21 mutationstreated with gefitinib …
蛋白酪氨酸磷酸酶SHP2 在非小细胞肺癌中的靶向治疗研究进展
周文斌， 张绪超 - 循证医学, 2022 - jebm.cn
… 了非小细胞肺癌(non⁃small cell lung cancer,NSCLC).SHP2 参与… of SHP2 inhibitors and their
applications in NSCLC,showing … contributes to gefitinib sensitivity of lung cancer cells with …
applications in NSCLC,showing … contributes to gefitinib sensitivity of lung cancer cells with …
[PDF][PDF] 非小细胞肺癌EGFR 基因突变的特征
于恪， 张敏， 杜秀芳 - 海南医学, 2018 - hainanyixue.cn
… of non-small-cell lung cancer to gefitinib [Z]. 2004: 350, 2129-2139. [12] Paez JG, Janne
PA, Lee JC, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib …
PA, Lee JC, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib …
青年肺癌分子遗传学以及预后的研究进展
S Yong, X PAN - Jie Fang Jun Yi Xue Za Zhi, 2017 - search.proquest.com
… Advanced non-small cell lung cancer in patients aged 45 years or younger: outcomes and
prognostic factors[ J]. BMC Cancer… Treatment strategy of Gefitinib in non-small cell lung cancer[…
prognostic factors[ J]. BMC Cancer… Treatment strategy of Gefitinib in non-small cell lung cancer[…
康莱特配伍吉非替尼治疗对晚期非小细胞肺癌患者免疫功能和生活质量的影响
杨玲， 田云， 杨浩， 张琳， 金蕊 - Progress in Modern …, 2016 - search.ebscohost.com
… ratio in patients with non-small cell lung cancer: a systemic review and meta-analysis [J]. Int
… a prognostic marker in patients with non-small cell lung cancer receiving gefitinib[J]. Mol Clin …
… a prognostic marker in patients with non-small cell lung cancer receiving gefitinib[J]. Mol Clin …